Zoetis faces challenges such as a recent earnings growth of 5.9%, which falls short of its five-year average. The net profit margin has also decreased to 26.3% from 26.9% last year, highlighting ...

(a) The condensed consolidated statements of income present the nine months ended September 30, 2024 and 2023. Subsidiaries operating outside the United States are included for the nine months ...

Zoetis raised its full-year guidance, forecasting revenue between $9.2 billion and $9.3 billion, and adjusting EPS between $5.86 and $5.92. Zoetis remains optimistic about its growth trajectory ...

Shares of the animal healthcare company rose nearly 3% in premarket trading after Zoetis also beat Wall Street's estimates for third-quarter results. Zoetis posted revenue of $2.39 billion in the ...

On the positive side, China only represents 3.7% of Zoetis's total revenue. Zoetis's osteoarthritis pain franchise, LIBRELA and SOLENSIA, could become a significant growth driver for the company's ...

FRESNO COUNTY, Calif. (KFSN) -- Health officials are investigating a rabies exposure in a Fresno County resident. The Department of Public Health tells Action News a Fresno resident is suspected ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE ... will represent the company and respond to questions from analysts at 3:00 p.m. GMT. Investors and other interested parties will be able ...

(RTTNews) - Zoetis Inc. (ZTS) revealed earnings for its third quarter that increased from last year and beat the Street estimates. The company's bottom line came in at $682 million, or $1.50 per ...

Seven analysts surveyed by Zacks expected $2.29 billion. Zoetis expects full-year earnings in the range of $5.86 to $5.92 per share, with revenue in the range of $9.2 billion to $9.3 billion.